AB Science - Company & Market Research Reports

Following a company allows Research and Markets to customize your experience and provide personalized recommendations.

AB Science is a pharmaceutical company specializing in the discovery, development, and commercialization of novel targeted therapies named protein kinase inhibitors. Their therapies treat diseases such as cancers, inflammatory diseases, and central nervous system diseases in both human and veterinary medicine. It serves hospitals and specialist physicians. The company was founded in 2001 and is headquartered in Paris, France.

From
From
From
From
From
From
From
From
Rheumatoid Arthritis - Pipeline Review, H2 2017 - Product Thumbnail Image

Rheumatoid Arthritis - Pipeline Review, H2 2017

  • Drug Pipelines
  • 1051 Pages
From
Rheumatoid Arthritis - Pipeline Review, H1 2017 - Product Thumbnail Image

Rheumatoid Arthritis - Pipeline Review, H1 2017

  • Drug Pipelines
  • 1020 Pages
From
Pancreatic Cancer - Pipeline Review, H2 2018 - Product Thumbnail Image

Pancreatic Cancer - Pipeline Review, H2 2018

  • Drug Pipelines
  • 2787 Pages
From
Colorectal Cancer - Pipeline Review, H2 2018 - Product Thumbnail Image

Colorectal Cancer - Pipeline Review, H2 2018

  • Drug Pipelines
  • 2548 Pages
From
From
Alzheimer's Disease - Pipeline Review, H2 2018 - Product Thumbnail Image

Alzheimer's Disease - Pipeline Review, H2 2018

  • Drug Pipelines
  • 1333 Pages
From
Pancreatic Cancer - Pipeline Review, H1 2018 - Product Thumbnail Image

Pancreatic Cancer - Pipeline Review, H1 2018

  • Drug Pipelines
  • 2509 Pages
From
Loading Indicator
adroll